- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02173535
Quantitative Study of New Limbal Ring Prototypes
June 18, 2018 updated by: Johnson & Johnson Vision Care, Inc.
The study is designed to test five new soft contact lens color pattern variants to determine whether the test lens makes the wearers eyes look bigger, more defined or enhances their overall appearance.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
257
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Kowloon
-
Hung Hom, Kowloon, Hong Kong
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 39 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- The subject must be at least 18 years of age and no more than 39 years of age (inclusive)
- Subjects must be Asian female
- Subjects must be able to read Chinese
- Subjects' monthly household income must be above HKD$ 10,000
- Subjects must be habitual soft contact lens wearer or habitual limbal lens wearer or have a history of previous habitual lens wear.
- Subjects' current/previous habitual lens must be in the disposable soft lens modality (ranging from daily to monthly)
- Subjects must have dark colored iris (black, brown, or brown hazel)
- Subjects must be "concept acceptors". Concept acceptors are subjects that are willing to try new circle contact lenses.
- Subjects must be classified as either 'Classic' or 'Vogue' on a Pattern Evaluation Screening Questionnaire.
- Subjects must have acceptable near vision (without vision correction) and be able to see the test article lenses in the mirror 30 cm or closer.
- Subjects must have best corrected visual acuity of 20/40 (Snellen or equivalent) or better in each eye.
- Subjects must possess a functional/usable pair of spectacles and bring them to the visit (only if applicable-to the investigators discretion)
- Subjects must read, understand, and sign the Statement of Informed Consent
- Subjects must appear able and willing to adhere to the instructions set forth in this clinical protocol
Exclusion Criteria:
- Subjects, or subjects' family member within the same household, that work for the following entities/companies: Government, advertising, marketing research or consultancy, media or public relations, companies that make, distribute or sell eyewear or contact lenses, eyecare practice (optometrist, ophthalmologist, optician) or the research center conducting the study
- Habitual wearers of rigid gas permeable lenses within the last 3 months
- Habitual soft conventional contact lens wearers (conventional lenses defined as replacement modality of greater than 1 month)
- Any color deficiencies, by self report
- Currently pregnant or breast-feeding a baby
- Diabetes
- Any ocular or systemic allergies or diseases which may interfere with contact lens wear
- Any systemic disease, autoimmune disease, or use of medication which may interfere with contact lens wear, at the investigator's discretion
- Any infectious diseases (e.g. hepatitis, tuberculosis) or a contagious immunosuppressive disease (e.g. HIV), by self report
- Any grade 3 or greater Biomicroscopy findings (this includes, corneal edema, corneal staining, corneal vascularization, conjunctival injection, tarsal abnormalities, bulbar injection) on the FDA classification scale
- Any active ocular abnormalities/conditions that may interfere with contact lens wear (this includes, but not limited to, chalazia, recurrent styes, pterygium, infection, etc.)
- Any corneal distortion or moderate or above corneal distortion by self report
- History of any corneal refractive surgery
- Habitual contact lens is multifocal, monovision or worn as extended wear
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: etafilcon test contact lens Variant AP
|
Subject will complete a questionnaire regarding cosmetic effect of the lens post insertion, then remove the lens.
Subject will complete a questionnaire regarding cosmetic effect of the lens post insertion, then remove the lens.
Subject will complete a questionnaire regarding cosmetic effect of the lens post insertion, then remove the lens.
Subject will complete a questionnaire regarding cosmetic effect of the lens post insertion, then remove the lens.
Subject will complete a questionnaire regarding cosmetic effect of the lens post insertion, then remove the lens.
|
|
Experimental: etafilcon test contact lens Variant JG
|
Subject will complete a questionnaire regarding cosmetic effect of the lens post insertion, then remove the lens.
Subject will complete a questionnaire regarding cosmetic effect of the lens post insertion, then remove the lens.
Subject will complete a questionnaire regarding cosmetic effect of the lens post insertion, then remove the lens.
Subject will complete a questionnaire regarding cosmetic effect of the lens post insertion, then remove the lens.
Subject will complete a questionnaire regarding cosmetic effect of the lens post insertion, then remove the lens.
|
|
Experimental: etafilcon test contact lens Variant CS
|
Subject will complete a questionnaire regarding cosmetic effect of the lens post insertion, then remove the lens.
Subject will complete a questionnaire regarding cosmetic effect of the lens post insertion, then remove the lens.
Subject will complete a questionnaire regarding cosmetic effect of the lens post insertion, then remove the lens.
Subject will complete a questionnaire regarding cosmetic effect of the lens post insertion, then remove the lens.
Subject will complete a questionnaire regarding cosmetic effect of the lens post insertion, then remove the lens.
|
|
Experimental: etafilcon test contact lens Variant VC
|
Subject will complete a questionnaire regarding cosmetic effect of the lens post insertion, then remove the lens.
Subject will complete a questionnaire regarding cosmetic effect of the lens post insertion, then remove the lens.
Subject will complete a questionnaire regarding cosmetic effect of the lens post insertion, then remove the lens.
Subject will complete a questionnaire regarding cosmetic effect of the lens post insertion, then remove the lens.
Subject will complete a questionnaire regarding cosmetic effect of the lens post insertion, then remove the lens.
|
|
Experimental: etafilcon test contact lens Variant LA
|
Subject will complete a questionnaire regarding cosmetic effect of the lens post insertion, then remove the lens.
Subject will complete a questionnaire regarding cosmetic effect of the lens post insertion, then remove the lens.
Subject will complete a questionnaire regarding cosmetic effect of the lens post insertion, then remove the lens.
Subject will complete a questionnaire regarding cosmetic effect of the lens post insertion, then remove the lens.
Subject will complete a questionnaire regarding cosmetic effect of the lens post insertion, then remove the lens.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Subject in Agreement (Bigger Eyes)
Time Frame: 15-20 Minutes Post Lens Insertion
|
Subjects' responses to the question "Make my eye look bigger" were categorized into a binary variable.
If a subject responded "Agrees Somewhat" or "Agrees Strongly" then response=1.
If a subject responds "Neither Agrees nor Disagrees", "Disagrees Somewhat" "Disagrees Strongly" then response=0.
The number of subjects with response=1 was reported for each lens.
|
15-20 Minutes Post Lens Insertion
|
|
Number of Subject in Agreement (Defines Eyes)
Time Frame: 15-20 Minutes Post Lens Insertion
|
Subjects' responses to the question "Define my eye" were categorized into a binary variable.
If a subject responded "Agrees Somewhat" or "Agrees Strongly" then response=1.
If a subject responds "Neither Agrees nor Disagrees", "Disagrees Somewhat" "Disagrees Strongly" then response=0.
The number of subjects with response=1 was reported for each lens.
|
15-20 Minutes Post Lens Insertion
|
|
Number of Subject in Agreement (Enhance Eyes)
Time Frame: 15-20 Minutes Post Lens Insertion
|
Subjects' responses to the question "Enhance my overall appearance" were categorized into a binary variable.
If a subject responded "Agrees Somewhat" or "Agrees Strongly" then response=1.
If a subject responds "Neither Agrees nor Disagrees", "Disagrees Somewhat" "Disagrees Strongly" then response=0.
The number of subjects with response=1 was reported for each lens.
|
15-20 Minutes Post Lens Insertion
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2014
Primary Completion (Actual)
June 1, 2014
Study Completion (Actual)
June 1, 2014
Study Registration Dates
First Submitted
May 20, 2014
First Submitted That Met QC Criteria
June 23, 2014
First Posted (Estimate)
June 25, 2014
Study Record Updates
Last Update Posted (Actual)
June 19, 2018
Last Update Submitted That Met QC Criteria
June 18, 2018
Last Verified
June 1, 2017
More Information
Terms related to this study
Other Study ID Numbers
- CR-5590
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cosmetic Effect
-
Vitro Biopharma Inc.CompletedCosmetic EffectUnited States
-
Superior UniversityCompletedCosmetic Product Causing Toxic EffectPakistan
-
Istanbul University - Cerrahpasa (IUC)CompletedMotivational Interview | Cosmetic Product Causing Toxic EffectTurkey
-
Alcon ResearchWithdrawn
-
Christie Medical Holdings, Inc.Completed
-
CIBA VISIONCompletedCosmetic Appearance
-
Alcon ResearchWithdrawn
-
Seoul National University HospitalUnknown
-
CIBA VISIONCompletedCosmetic AppearanceSingapore
-
Ungku Shahrin Medical Aesthetic Research & Innovation...Completed
Clinical Trials on etafilcon test contact lens Variant AP
-
Johnson & Johnson Vision Care, Inc.CompletedVision CorrectionUnited States, United Kingdom
-
Johnson & Johnson Vision Care, Inc.Visioncare Research Ltd.Completed
-
Johnson & Johnson Vision Care, Inc.CompletedAstigmatismUnited States
-
Johnson & Johnson Vision Care, Inc.Completed
-
CooperVision, Inc.Completed
-
CIBA VISIONCompleted
-
University of HoustonCompleted
-
Alcon ResearchCompleted
-
Johnson & Johnson Vision Care, Inc.Completed
-
CIBA VISIONCompletedMyopia | HyperopiaCanada